Aytu Biopharma, Inc.

AYTU Nasdaq SEC CIK 1385818
Follow Aytu Biopharma Weekly email: filings, results

Financials

Reported figures only · latest: Q1 2027 USD · US GAAP
Revenue, last quarter $14.8M +6.9% vs same quarter last year
Net income −$3.9M
EPS, diluted −$0.20 −195.2% vs same quarter last year
Operating cash flow −$275K +55.5% vs same quarter last year
Revenue by quarter
$16.2M
$18.5M
$15.1M
$13.9M
$15.2M
$12.4M
$16.1M
$14.8M
Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26 Q4 26 Q1 27

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$200M−$100M$0$100M$200MFY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearRevenueNet income
FY26$57.6M−$14.3M
FY25$66.4M−$13.6M
FY24$65.2M−$15.8M
FY23$107.4M−$17.1M
FY22$96.7M−$108.8M
FY21$65.6M−$58.3M
FY20$27.6M−$13.6M
FY19$7.3M−$27.1M
FY18$3.7M−$10.2M
FY17$3.2M−$22.5M
FY16$2.6M−$28.2M
FY15$261.8K−$7.7M
FY14$58.9K−$5.6M
FY13-−$59.7K
FY12-−$136.8K
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−15000%−10000%−5000%0%5000%FY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearGross marginOperating marginNet margin
FY2664%−14.4%−24.8%
FY2569%−11.8%−20.5%
FY2475.3%−2.4%−24.2%
FY2362%−15.9%−15.9%
FY2254.1%−113.7%−112.5%
FY2144.5%−89.7%−88.8%
FY2070%−76.5%−49.3%
FY1969.9%−230.1%−370.6%
FY1844%−538.2%−278.3%
FY1756%−624.7%−698.7%
FY1662.6%−847%−1099.7%
FY1566.3%−2915.5%−2950.3%
FY14-−10770.3%−9466.8%
FY13---
FY12---
Free cash flowOperating cash flow minus capital expenditure
−$30M−$20M−$10M$0$10MFY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearFree cash flow
FY26$3.3M
FY25−$2.2M
FY24−$1.7M
FY23-
FY22−$28.8M
FY21−$28.3M
FY20−$28.4M
FY19−$13.9M
FY18−$16M
FY17−$13.9M
FY16−$10.9M
FY15−$6.6M
FY14−$47K
FY13-
FY12-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Aytu Biopharma
  • Healthcare median
−10000%−7500%−5000%−2500%0%FY12FY14FY16FY18FY20FY22FY24FY26
Show the numbers
YearAytu BiopharmaHealthcare median
FY26−24.8%−11.1%
FY25−20.5%−30.6%
FY24−24.2%−47%
FY23−15.9%−58%
FY22−112.5%−80.4%
FY21−88.8%−71.9%
FY20−49.3%−62.2%
FY19−370.6%−46.3%
FY18−278.3%−49.6%
FY17−698.7%−45.9%
FY16−1099.7%−36%
FY15−2950.3%−38.4%
FY14−9466.8%−35.5%
FY13-−37.1%
FY12-−29.1%